Paragon Private Wealth Management, LLC
Source: SEC Form 13F · as of Mar 2026Paragon Private Wealth Management, LLC holds 14 biotech & pharma companies tracked by BioSniper, totaling $12.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$12.5M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 2,969 | $2.7M |
| ABBVAbbVie Inc. | 10,599 | $2.3M |
| JNJJOHNSON & JOHNSON | 7,655 | $1.9M |
| ABTABBOTT LABORATORIES | 13,663 | $1.4M |
| AMGNAMGEN INC | 2,894 | $1.0M |
| MCKMcKesson Corporation | 608 | $526K |
| PMPhilip Morris International Inc | 2,675 | $442K |
| MRKMerck & Co., Inc. | 3,543 | $426K |
| SNYSanofi | 8,802 | $424K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,346 | $364K |
| GILDGILEAD SCIENCES, INC. | 1,965 | $274K |
| CAHCardinal Health Inc. | 1,221 | $258K |
| PFEPFIZER INC | 8,974 | $252K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 486 | $217K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.